UK Markets closed

SENS Jan 2024 1.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.25000.0000 (0.00%)
As of 07:57AM EDT. Market open.
Full screen
Previous close0.2500
OpenN/A
Bid0.2000
Ask0.3500
Strike1.00
Expiry date2024-01-19
Day's range0.2500 - 0.2500
Contract rangeN/A
VolumeN/A
Open interest10
  • Business Wire

    Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

    GERMANTOWN, Md., June 16, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has received CE Mark approval for the next-generation Eversense® E3 CGM System, the longest-lasting system available, with exceptional accuracy. The CE Mark approval confirms that the Eversense E3 meets the requirements of the

  • Business Wire

    Senseonics to Participate in the Jefferies Healthcare Conference

    GERMANTOWN, Md., May 26, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.

  • Business Wire

    Senseonics to Participate in the H.C. Wainwright Global Investment Conference

    GERMANTOWN, Md., May 16, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming hybrid H.C. Wainwright Global Investment Conference.